Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

RepliCel Life Sciences Inc (OTCQB:REPCF)

0.072
Delayed Data
As of Jul 28
 -0.0139 / -16.18%
Today’s Change
0.05
Today|||52-Week Range
0.34
-62.69%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
Revenue and IncomeNet Revenues0.004.0M0.000.00
 
 
Depreciation And Amortization6.1K5.9K6.9K5.5K
 
 
 
 
 
 
Operating ExpensesGross Income-6.1K---6.9K-5.5K
 
 
 
 
General Expenses4.5M3.5M4.7M3.9M
 
 
 
 
 
Research And Development1.1M1.4M1.8M1.8M
 
 
 
 
 
Total Operating Expenses4.5M3.5M4.7M3.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-4.5M518.3K-4.7M-3.9M
 
 
 
 
 
Extraordinary Credit1.1M0.000.002.8K
 
 
 
Extraordinary Charge0.00-136.0K-7.0K0.00
 
 
 
Other Expenses-5.7K-10.1K3.2K-12.1K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-3.4M372.2K-4.7M-3.9M
 
 
 
 
 
Income Taxes0.00-399.9K0.000.00
 
 
Net Income-3.4M-27.7K-4.7M-3.9M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS42.7M45.2M50.9M56.9M
 
 
 
 
 
Shares To Calculate EPS Diluted42.7M45.2M50.9M56.9M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.08$0.00-$0.09-$0.07
 
 
 
 
EPS Diluted-$0.08-$0.00-$0.09-$0.07